Clinical trial
A Prospective Multi-center Randomized Study of the Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses
NCT02092519 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multi-center Randomized Study of the Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses
- Lead sponsor
- Changi General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- February 28, 2015
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic diseases, pancreatic neoplasm